We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Exploring the Impact of Multiple Pregnancies on Subclinical Left Ventricular Function in Healthy Women

MedXY Editorial Team•Aug 18, 2026•Cardiology
PregnancyLeft Ventricular DysfunctionParityglobal longitudinal strain

Highlight

• Higher parity correlates with subclinical left ventricular dysfunction detected by reduced global longitudinal strain (GLS) despite preserved ejection fraction.
• Each additional pregnancy leads to a measurable decline in myocardial strain independent of confounding factors.
• The association is stronger in older women and those with short interpregnancy intervals, indicating potential cumulative cardiovascular stress.
• GLS values remain within physiological pregnancy ranges, but the downward trend suggests long-term cardiac impact that requires further research.

Study Background

Pregnancy induces profound and complex cardiovascular adaptations to accommodate increased metabolic demands, including increased blood volume, cardiac output, and heart rate. While these changes are typically reversible postpartum in healthy women, repeated pregnancies might impose incremental stress on cardiac structure and function. Parity — the number of times a woman has given birth — has been implicated as a factor that could cumulatively affect cardiovascular health. Notably, subclinical myocardial changes may precede overt dysfunction, thereby offering an opportunity for early detection using sensitive imaging modalities such as advanced echocardiography with speckle-tracking-derived global longitudinal strain (GLS) analysis. However, the exact relationship between parity and subtle myocardial dysfunction during pregnancy remains poorly characterized, especially in healthy women without established cardiovascular disease or risk factors. Understanding this relationship carries clinical importance given the rising prevalence of high parity and the long-term cardiovascular risks associated with pregnancy-related cardiac remodeling.

Study Design

The present study was a prospective, cross-sectional investigation conducted on a cohort of 605 healthy pregnant women. Eligibility criteria excluded individuals with cardiovascular diseases or risk factors to isolate parity effects on cardiac function. Participants underwent comprehensive echocardiographic assessment, including speckle-tracking echocardiography to measure GLS during the third trimester, specifically between 28 and 32 weeks of gestation. Respondents were stratified into two groups: those with fewer than four pregnancies (<4) and those with four or more (≥4). Multivariable linear regression analyses were performed to examine the relationship between parity and GLS, adjusting for potential confounders including age, body mass index, and blood pressure. Additional subgroup analyses considered the influence of maternal age and interpregnancy intervals on myocardial strain.

Key Findings

The overall cohort had a mean age of 30.9 years and a mean parity of 3.8 pregnancies. Despite all women exhibiting preserved left ventricular ejection fractions averaging 63.2%, an incremental increase in parity was independently associated with a worsening GLS score — a 0.21-unit decline in strain per each additional pregnancy (β = 0.21, 95% CI: 0.13-0.29, p < 0.001). Comparatively, women with high parity (≥4 pregnancies) had significantly lower mean GLS values (-19.1% ± 2.5%) than those with fewer pregnancies (-20.5% ± 4.1%, p < 0.001), indicating a relative decrease in myocardial deformation despite preserved systolic function.

Multivariable regression confirmed that high parity remained an independent predictor of reduced GLS (β = 1.18, 95% CI: 0.52-1.84, p < 0.001) after adjustment. Notably, the effect size was more prominent among older women and those with interpregnancy intervals shorter than 18 months, suggesting that maternal age and rapid successive pregnancies might exacerbate subclinical myocardial strain reduction.

Importantly, while GLS values were decreased with parity, they remained within physiological ranges expected during pregnancy, underscoring subtle but not yet clinically overt myocardial impairment.

Expert Commentary

This study provides robust prospective evidence linking higher parity to measurable subclinical myocardial dysfunction during pregnancy, as captured by sensitive strain imaging techniques. The use of GLS as a quantitative marker of myocardial deformation offers enhanced sensitivity compared to conventional metrics like ejection fraction, which often remain normal until later stages of dysfunction.

The findings align with the hypothesis that repeated pregnancies impose cumulative hemodynamic stress on the maternal heart, potentially accelerating myocardial remodeling processes. The stronger association observed in women with shorter interpregnancy intervals supports the concept of insufficient cardiac recovery time between pregnancies as a mechanism exacerbating strain alterations.

Limitations include the cross-sectional design, which precludes causal inferences or assessment of long-term outcomes postpartum. Furthermore, the study focused on a healthy population, so results may differ in women with preexisting cardiovascular conditions or other comorbidities. Future longitudinal studies are warranted to determine whether parity-associated subclinical dysfunction translates into increased risk of clinical heart failure or cardiovascular morbidity later in life.

Conclusion

This study highlights an independent and continuous relationship between parity and reduced subclinical myocardial strain in otherwise healthy pregnant women, despite preserved conventional systolic measures. The observed GLS decline with increasing number of pregnancies, particularly in older women and those with brief intervals between pregnancies, underscores the importance of cardiovascular monitoring in multiparous populations. While current findings remain within normal pregnancy physiology, they suggest cumulative hemodynamic effects that merit further investigation to clarify their clinical significance and inform strategies to optimize maternal cardiovascular health.

Funding and Clinical Trials

The publication did not specify funding sources or registry information relevant to clinical trial registration.

References

1. Kümet Ö, Polat F, Uzaldı İ, Kaya AF, Ayhan G, Özbek E, Can V. Association Between Parity and Subclinical Left Ventricular Dysfunction in Healthy Pregnant Women: A Prospective Cross-Sectional Study. BJOG. 2026;133(9):1785-1794. PMID: 41889162.
2. Melchiorre K, Sharma R, Thilaganathan B. Cardiovascular implications in pregnancy. BJOG. 2014;121 Suppl 4:21-32.
3. Thilaganathan B, Kalafat E. Cardiovascular system in pregnancy. Circulation. 2019;139(8):829-836.
4. Kametas NA, Rodriguez A, Morales-Roselló J, et al. Effect of parity on cardiovascular changes during pregnancy: an echocardiographic study. Ultrasound Obstet Gynecol. 2017;49(4):501-507.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Understanding HPA-1a Alloimmunisation in Pregnancy: Insights from a Multi-Ethnic Prospective StudyThis study reveals the population prevalence and incident risk of HPA-1a alloimmunisation in pregnancy across diverse ethnic groups, highlighting its rarity and establishing a framework for risk assessment in foetal-neonatal alloimmune throSep 17, 2026Psychostimulant Continuation and Postpartum Mental Health in Pregnant People With Attention-Deficit/Hyperactivity Disorder: A Clinical Evidence ReviewThis review synthesizes current evidence on the impact of continuing psychostimulant treatment during pregnancy on postpartum mental health outcomes among people with ADHD, highlighting key findings and clinical implications from recent larSep 9, 2026Antiseizure Medication Use During Pregnancy: Implications for Fetal Growth from the EURAP RegistryA comprehensive cohort study from the EURAP registry reveals that antiseizure medication, especially polytherapy and certain monotherapies, increases the risk of poor fetal growth, underscoring the need for optimized treatment strategies duSep 5, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing &amp; care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Balancing Maternal Mental Health and Fetal Safety: Insights on Depression and SSRI Use During Pregnancy
This article reviews the complex interplay between major depressive disorder during pregnancy and selective serotonin reuptake inhibitor treatment, highlighting the importance of prioritizing maternal mental health to optimize outcomes for
Aug 18, 2026
AI-Enabled ECG as a New Surveillance Tool for Left Ventricular Dysfunction in Hypertrophic Cardiomyopathy on MavacamtenThis study explores the potential of an AI-powered ECG tool to monitor left ventricular systolic dysfunction in hypertrophic cardiomyopathy patients treated with mavacamten, offering a less burdensome alternative to frequent echocardiogramsAug 12, 2026
Impact of Texas Abortion Ban on Critical Illness in Hospitalized Pregnant Women: A Retrospective Cohort AnalysisThe Texas Senate Bill 8 abortion ban is linked to an increased rate of critical illness, sepsis, and infections among hospitalized pregnant women with high-risk features, highlighting significant implications for maternal healthcare in restAug 18, 2026